Show simple item record

AuthorOmar, Nabil E.
AuthorElewa, Hazem
Available date2023-08-29T07:01:05Z
Publication Date2023-07-01
Publication NamePharmacogenetics and Genomics
Identifierhttp://dx.doi.org/10.1097/FPC.0000000000000497
CitationOmar, Nabil E.a,b; Elewa, Hazemb. Cisplatin-induced ototoxicity: a novel approach to an ancient problem. Pharmacogenetics and Genomics 33(5):p 111-115, July 2023. | DOI: 10.1097/FPC.0000000000000497
ISSN17446872
URIhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85160970082&origin=inward
URIhttp://hdl.handle.net/10576/46959
AbstractWith the scarcity of pharmacological otoprotective agents against cisplatin-induced ototoxicity (CIO), researchers find themselves compelled to look at and navigate all possible strategies to identify ways to prevent CIO. One of these promising strategies is pharmacogenomic implementation. This strategy aims for identifying and detecting high-risk genetic variants to tailor cisplatin therapy to reach the best survival outcomes with the least risk of ototoxicity.
Languageen
PublisherLippincott, Williams & Wilkins
Subjectcisplatin
hearing loss
ototoxicity
personalized medicine
pharmacogenomics
TitleCisplatin-induced ototoxicity: A novel approach to an ancient problem
TypeArticle
Pagination111-115
Issue Number5
Volume Number33
ESSN1744-6880
dc.accessType Abstract Only


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record